Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

Factors associated with commencing and ceasing opioid therapy in patients with rheumatoid arthritis.

Black RJ, Richards B, Lester S, Buchbinder R, Barrett C, Lassere M, March L, Hill CL.

Semin Arthritis Rheum. 2019 Jun 10. pii: S0049-0172(18)30582-1. doi: 10.1016/j.semarthrit.2019.06.003. [Epub ahead of print]

PMID:
31280936
2.

Investigating Dimensions of Stiffness in Rheumatoid and Psoriatic Arthritis: The Australian Rheumatology Association Database Registry and OMERACT Collaboration.

Sinnathurai P, Bartlett SJ, Halls S, Hewlett S, Orbai AM, Buchbinder R, Henderson L, Hill CL, Lassere M, March L.

J Rheumatol. 2019 Apr 1. pii: jrheum.181251. doi: 10.3899/jrheum.181251. [Epub ahead of print]

PMID:
30936277
3.
4.

Cardiovascular risk management in rheumatoid and psoriatic arthritis: online survey results from a national cohort study.

Sinnathurai P, Capon A, Buchbinder R, Chand V, Henderson L, Lassere M, March L.

BMC Rheumatol. 2018 Sep 6;2:25. doi: 10.1186/s41927-018-0032-9. eCollection 2018.

5.

Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study.

Lee JL, Sinnathurai P, Buchbinder R, Hill C, Lassere M, March L.

Arthritis Res Ther. 2018 Aug 7;20(1):171. doi: 10.1186/s13075-018-1669-x.

6.

Comorbidity in psoriatic arthritis and rheumatoid arthritis.

Sinnathurai P, Buchbinder R, Hill C, Lassere M, March L.

Intern Med J. 2018 Nov;48(11):1360-1368. doi: 10.1111/imj.14046.

PMID:
30047189
7.

Protocol of the randomised placebo controlled pilot trial of the management of acute sciatica (SCIATICA): a feasibility study.

Lassere MN, Johnson KR, Thom J, Pickard G, Smerdely P.

BMJ Open. 2018 Jul 5;8(7):e020435. doi: 10.1136/bmjopen-2017-020435.

8.

Serum urate as surrogate endpoint for flares in people with gout: A systematic review and meta-regression analysis.

Stamp L, Morillon MB, Taylor WJ, Dalbeth N, Singh JA, Lassere M, Christensen R.

Semin Arthritis Rheum. 2018 Oct;48(2):293-301. doi: 10.1016/j.semarthrit.2018.02.009. Epub 2018 Feb 21.

PMID:
29566967
9.

Variability in the Reporting of Serum Urate and Flares in Gout Clinical Trials: Need for Minimum Reporting Requirements.

Stamp LK, Morillon MB, Taylor WJ, Dalbeth N, Singh JA, Lassere M, Christensen R.

J Rheumatol. 2018 Mar;45(3):419-424. doi: 10.3899/jrheum.170911. Epub 2017 Dec 15.

PMID:
29247147
10.

Factors associated with oral glucocorticoid use in patients with rheumatoid arthritis: a drug use study from a prospective national biologics registry.

Black RJ, Lester S, Buchbinder R, Barrett C, Lassere M, March L, Whittle S, Hill CL.

Arthritis Res Ther. 2017 Nov 15;19(1):253. doi: 10.1186/s13075-017-1461-3.

11.

18F-FDG PET-Derived Tumor Blood Flow Changes After 1 Cycle of Neoadjuvant Chemotherapy Predicts Outcome in Triple-Negative Breast Cancer.

Humbert O, Riedinger JM, Vrigneaud JM, Kanoun S, Dygai-Cochet I, Berriolo-Riedinger A, Toubeau M, Depardon E, Lassere M, Tisserand S, Fumoleau P, Brunotte F, Cochet A.

J Nucl Med. 2016 Nov;57(11):1707-1712. Epub 2016 Apr 21.

12.

Real-time colour pictorial radiation monitoring during coronary angiography: effect on patient peak skin and total dose during coronary angiography.

Wilson SM, Prasan AM, Virdi A, Lassere M, Ison G, Ramsay DR, Weaver JC.

EuroIntervention. 2016 Oct 10;12(8):e939-e947. doi: 10.4244/EIJV12I8A156.

13.

Using serum urate as a validated surrogate end point for flares in patients with gout: protocol for a systematic review and meta-regression analysis.

Morillon MB, Stamp L, Taylor W, Fransen J, Dalbeth N, Singh JA, Christensen R, Lassere M.

BMJ Open. 2016 Sep 20;6(9):e012026. doi: 10.1136/bmjopen-2016-012026.

14.
16.

Risk factors for herpes zoster in rheumatoid arthritis patients: the role of tumour necrosis factor-α inhibitors.

Segan J, Staples MP, March L, Lassere M, Chakravarty EF, Buchbinder R.

Intern Med J. 2015 Mar;45(3):310-8. doi: 10.1111/imj.12679.

PMID:
25565419
17.

Smoking did not modify the effects of anti-TNF treatment on health-related quality of life among Australian ankylosing spondylitis patients.

Kydd AS, Chen JS, Makovey J, Chand V, Henderson L, Buchbinder R, Lassere M, March LM.

Rheumatology (Oxford). 2015 Feb;54(2):310-7. doi: 10.1093/rheumatology/keu314. Epub 2014 Aug 29.

PMID:
25173348
18.

Evaluating surrogacy metrics and investigating approval decisions of progression-free survival (PFS) in metastatic renal cell cancer: a systematic review.

Johnson KR, Liauw W, Lassere MN.

Ann Oncol. 2015 Mar;26(3):485-96. doi: 10.1093/annonc/mdu267. Epub 2014 Jul 23. Review.

PMID:
25057168
19.

The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study.

Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, Williams B, Gabriel S, Lassere M, Johns N, Buchbinder R, Woolf A, March L.

Ann Rheum Dis. 2014 Jul;73(7):1316-22. doi: 10.1136/annrheumdis-2013-204627. Epub 2014 Feb 18.

PMID:
24550173
20.

Determining a magnetic resonance imaging inflammatory activity acceptable state without subsequent radiographic progression in rheumatoid arthritis: results from a followup MRI study of 254 patients in clinical remission or low disease activity.

Gandjbakhch F, Haavardsholm EA, Conaghan PG, Ejbjerg B, Foltz V, Brown AK, Døhn UM, Lassere M, Freeston JE, Olsen IC, Bøyesen P, Bird P, Fautrel B, Hetland ML, Emery P, Bourgeois P, Hørslev-Petersen K, Kvien TK, McQueen FM, Østergaard M.

J Rheumatol. 2014 Feb;41(2):398-406. doi: 10.3899/jrheum.131088. Epub 2013 Dec 15.

PMID:
24334647
21.

Update on the OMERACT magnetic resonance imaging task force: research and future directions.

Conaghan PG, McQueen FM, Bird P, Peterfy C, Haavardsholm E, Gandjbakhch F, Eshed I, Haugen IK, Lillegraven S, Døhn UM, Ejbjerg B, Foltz V, Coates L, Bøyesen P, Hermann KG, Freeston J, Lassere M, O'Connor P, Emery P, Genant H, Østergaard M.

J Rheumatol. 2014 Feb;41(2):383-5. doi: 10.3899/jrheum.131085. Epub 2013 Dec 1.

PMID:
24293579
22.

Comparative effectiveness of anti-tumor necrosis factor drugs on health-related quality of life among patients with inflammatory arthritis.

Chen JS, Makovey J, Lassere M, Buchbinder R, March LM.

Arthritis Care Res (Hoboken). 2014 Mar;66(3):464-72. doi: 10.1002/acr.22151.

23.

Reliability and longitudinal validity of computer-assisted methods for measuring joint damage progression in subjects with rheumatoid arthritis.

Poh MQ, Lassere M, Bird P, Edmonds J.

J Rheumatol. 2013 Jan;40(1):23-9. doi: 10.3899/jrheum.120549. Epub 2012 Nov 1.

PMID:
23118111
25.

How many life years are lost in patients with rheumatoid arthritis? Secular cause-specific and all-cause mortality in rheumatoid arthritis, and their predictors in a long-term Australian cohort study.

Lassere MN, Rappo J, Portek IJ, Sturgess A, Edmonds JP.

Intern Med J. 2013 Jan;43(1):66-72. doi: 10.1111/j.1445-5994.2012.02727.x.

PMID:
22289054
26.

Clinicians adopting evidence based guidelines: a case study with thromboprophylaxis.

Chapman NH, Lazar SP, Fry M, Lassere MN, Chong BH.

BMC Health Serv Res. 2011 Sep 28;11:240. doi: 10.1186/1472-6963-11-240.

27.

Development and preliminary validation of a magnetic resonance imaging joint space narrowing score for use in rheumatoid arthritis: potential adjunct to the OMERACT RA MRI scoring system.

Ostergaard M, Bøyesen P, Eshed I, Gandjbakhch F, Lillegraven S, Bird P, Foltz V, Boonen A, Lassere M, Hermann KG, Anandarajah A, Døhn UM, Freeston J, Peterfy CG, Genant HK, Haavardsholm EA, McQueen FM, Conaghan PG.

J Rheumatol. 2011 Sep;38(9):2045-50. doi: 10.3899/jrheum.110422.

PMID:
21885515
28.

Synovitis and osteitis are very frequent in rheumatoid arthritis clinical remission: results from an MRI study of 294 patients in clinical remission or low disease activity state.

Gandjbakhch F, Conaghan PG, Ejbjerg B, Haavardsholm EA, Foltz V, Brown AK, Møller Døhn U, Lassere M, Freeston J, Bøyesen P, Bird P, Fautrel B, Hetland ML, Emery P, Bourgeois P, Hørslev-Petersen K, Kvien TK, McQueen F, Ostergaard M.

J Rheumatol. 2011 Sep;38(9):2039-44. doi: 10.3899/jrheum.110421.

PMID:
21885514
29.

Update on research and future directions of the OMERACT MRI inflammatory arthritis group.

Conaghan PG, McQueen FM, Bird P, Peterfy CG, Haavardsholm EA, Gandjbakhch F, Bøyesen P, Coates L, Ejbjerg B, Eshed I, Foltz V, Hermann KG, Freeston J, Lillegraven S, Lassere M, Wiell C, Anandarajah A, Duer-Jensen A, O'Connor P, Genant HK, Emery P, Ostergaard M.

J Rheumatol. 2011 Sep;38(9):2031-3. doi: 10.3899/jrheum.110419. Review.

PMID:
21885512
30.

Rheumatoid arthritis.

Carmona L, Cross M, Williams B, Lassere M, March L.

Best Pract Res Clin Rheumatol. 2010 Dec;24(6):733-45. doi: 10.1016/j.berh.2010.10.001. Review.

PMID:
21665122
31.

The Australian Rheumatology Association Database (ARAD).

Williams MP, Buchbinder R, March L, Lassere M.

Semin Arthritis Rheum. 2011 Feb;40(4):e2-3. doi: 10.1016/j.semarthrit.2010.10.001. Epub 2010 Dec 17. No abstract available.

PMID:
21168188
32.

Health-related quality of life and continuation rate on first-line anti-tumour necrosis factor therapy among rheumatoid arthritis patients from the Australian Rheumatology Association Database.

Staples MP, March L, Lassere M, Reid C, Buchbinder R.

Rheumatology (Oxford). 2011 Jan;50(1):166-75. doi: 10.1093/rheumatology/keq322. Epub 2010 Oct 7.

PMID:
20929971
33.
34.

A pathway and approach to biomarker validation and qualification for osteoarthritis clinical trials.

Hunter DJ, Losina E, Guermazi A, Burstein D, Lassere MN, Kraus V.

Curr Drug Targets. 2010 May;11(5):536-45. Review.

35.

Are reporting standards of diagnostic test evaluation unrealistic?

Lassere M.

J Rheumatol. 2010 Feb;37(2):220-2. doi: 10.3899/jrheum.091254. No abstract available.

PMID:
20147476
36.

Baseline comorbidities in a population-based cohort of rheumatoid arthritis patients receiving biological therapy: data from the Australian rheumatology association database.

Briggs AM, March L, Lassere M, Reid C, Henderson L, Murphy B, van den Haak R, Rischin A, Staples M, Buchbinder R.

Int J Rheumatol. 2009;2009:861481. doi: 10.1155/2009/861481. Epub 2009 Sep 1.

37.

Ankylosing spondylitis patients commencing biologic therapy have high baseline levels of comorbidity: a report from the Australian rheumatology association database.

Oldroyd J, Schachna L, Buchbinder R, Staples M, Murphy B, Bond M, Briggs A, Lassere M, March L.

Int J Rheumatol. 2009;2009:268569. doi: 10.1155/2009/268569. Epub 2009 Aug 2.

38.

The OMERACT psoriatic arthritis magnetic resonance imaging scoring system (PsAMRIS): definitions of key pathologies, suggested MRI sequences, and preliminary scoring system for PsA Hands.

Ostergaard M, McQueen F, Wiell C, Bird P, Bøyesen P, Ejbjerg B, Peterfy C, Gandjbakhch F, Duer-Jensen A, Coates L, Haavardsholm EA, Hermann KG, Lassere M, O'Connor P, Emery P, Genant H, Conaghan PG.

J Rheumatol. 2009 Aug;36(8):1816-24. doi: 10.3899/jrheum.090352. Erratum in: J Rheumatol. 2010 Oct;37(10):2198.

PMID:
19671819
39.

Testing an OMERACT MRI scoring system for peripheral psoriatic arthritis in cross-sectional and longitudinal settings.

McQueen F, Lassere M, Duer-Jensen A, Wiell C, Conaghan PG, Gandjbakhch F, Hermann KG, Bird P, Bøyesen P, Peterfy C, Ejbjerg B, Haavardsholm EA, Coates L, Ostergaard M.

J Rheumatol. 2009 Aug;36(8):1811-5. doi: 10.3899/jrheum.090351.

PMID:
19671818
40.

Reducing invasiveness, duration, and cost of magnetic resonance imaging in rheumatoid arthritis by omitting intravenous contrast injection -- Does it change the assessment of inflammatory and destructive joint changes by the OMERACT RAMRIS?

Ostergaard M, Conaghan PG, O'Connor P, Szkudlarek M, Klarlund M, Emery P, Peterfy C, Genant H, McQueen FM, Bird P, Lassere M, Ejbjerg B.

J Rheumatol. 2009 Aug;36(8):1806-10. doi: 10.3899/jrheum.090350. Erratum in: J Rheumatol. 2010 Oct;37(10):2198.

PMID:
19671817
41.

The OMERACT MRI inflammatory arthritis group: advances and future research priorities.

Conaghan PG, Bird P, McQueen F, Peterfy C, Bøyesen P, Gandjbakhch F, Duer-Jensen A, Haavardsholm EA, Ejbjerg B, Wiell C, Coates L, Hermann KG, O'Connor P, Lassere M, Freeston JE, Anandarajah A, Genant H, Emery P, Ostergaard M.

J Rheumatol. 2009 Aug;36(8):1803-5. doi: 10.3899/jrheum.090349. Erratum in: J Rheumatol. 2010 Oct;37(10):2198.

PMID:
19671816
42.

Stakeholder Satisfaction with the Australian Rheumatology Association Database (ARAD).

Briggs AM, March L, van den Haak R, Hay N, Henderson L, Murphy B, Wengier L, Lassere M, Bendrups A, Buchbinder R.

Patient. 2009 Mar 1;2(1):61-8.

PMID:
22273060
43.

Imaging: the need for standardization.

Lassere MN.

Best Pract Res Clin Rheumatol. 2008 Dec;22(6):1001-18. doi: 10.1016/j.berh.2008.09.003. Review.

PMID:
19041074
44.

LDL-cholesterol differences predicted survival benefit in statin trials by the surrogate threshold effect (STE).

Johnson KR, Freemantle N, Anthony DM, Lassere MN.

J Clin Epidemiol. 2009 Mar;62(3):328-36. doi: 10.1016/j.jclinepi.2008.06.004. Epub 2008 Oct 1. Review.

PMID:
18834708
45.

Guest authorship, mortality reporting, and integrity in rofecoxib studies.

Johnson KR, Lassere MN.

JAMA. 2008 Aug 27;300(8):900; author reply 904-6. doi: 10.1001/jama.300.8.900-a. No abstract available.

PMID:
18728255
47.

Effect of treatment with biological agents for arthritis in Australia: the Australian Rheumatology Association Database.

Buchbinder R, March L, Lassere M, Briggs AM, Portek I, Reid C, Meehan A, Henderson L, Wengier L, van den Haak R.

Intern Med J. 2007 Sep;37(9):591-600. Epub 2007 Jun 15.

PMID:
17573817
48.

Standardizing assessment and reporting of adverse effects in rheumatology clinical trials II: the Rheumatology Common Toxicity Criteria v.2.0.

Woodworth T, Furst DE, Alten R, Bingham CO 3rd, Yocum D, Sloan V, Tsuji W, Stevens R, Fries J, Witter J, Johnson K, Lassere M, Brooks P.

J Rheumatol. 2007 Jun;34(6):1401-14. Erratum in: J Rheumatol. 2014 Nov;41(11):2336. Bingham, Clifton [corrected to Bingham, Clifton O 3rd].

PMID:
17552067
49.

Rotator cuff tear in an elderly woman performing progressive resistance training: case report from a randomized controlled trial.

Cheema BS, Lassere M, Shnier R, Fiatarone Singh MA.

J Phys Act Health. 2007 Jan;4(1):113-20.

PMID:
17489013
50.

Developing a magnetic resonance imaging scoring system for peripheral psoriatic arthritis.

McQueen F, Lassere M, Bird P, Haavardsholm EA, Peterfy C, Conaghan PG, Ejbjerg B, Genant H, O'Connor P, Emery P, Østergaard M.

J Rheumatol. 2007 Apr;34(4):859-61.

PMID:
17407240

Supplemental Content

Loading ...
Support Center